AIV007
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AIV007, covering 2024-12-27 to 2025-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) [Phase 1]